T cell TET2 disruption cuts the breaks on antitumor CAR T cell therapy

Trends in immunology

Caitlin C Zebley, Ben Youngblood, Caitlin C Zebley, …, Ben Youngblood, Caitlin C Zebley, Ben Youngblood

• DOI: 10.1016/j.it.2023.03.008
• PMID: 36959018